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RESEARCH ARTICLE

Liposomal encapsulation of silver nanoparticles enhances
cytotoxicity and causes induction of reactive oxygen species‐
independent apoptosis
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Abstract

2

Silver nanoparticles (AgNP) are one of the most widely investigated metallic NPs due to their
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Institute, Dublin Institute of Technology, Kevin
Street, Dublin 8, Ireland

promising antibacterial activities. In recent years, AgNP research has shifted beyond antimicrobial
use to potential applications in the medical arena. This shift coupled with the extensive commer-
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cial applications of AgNP will further increase human exposure and the subsequent risk of
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the intracellular delivery and simultaneously mediate the associated cytotoxicity of the AgNP. It

adverse effects that may result from repeated exposures and inefficient delivery, meaning
research into improved AgNP delivery is of paramount importance. In this study, AgNP were
encapsulated in a natural biosurfactant, dipalmitoylphosphatidylcholine, in an attempt to enhance
was noted that because of the encapsulation, liposomal AgNP (Lipo‐AgNP) at 0.625 μg ml–1
induced significant cell death in THP1 cell lines a notably lower dose than that of the uncoated
AgNP induced cytotoxicity. The induced cytotoxicity was shown to result in an increased level
of DNA fragmentation resulting in a cell cycle interruption at the S phase. It was shown that
the predominate form of cell death upon exposure to both uncoated AgNP and Lipo‐AgNP was
apoptosis. However, a reactive oxygen species‐independent activation of the executioner
caspases 3/7 occurred when exposed to the Lipo‐AgNP. These findings showed that encapsulation of AgNP enhance AgNP cytotoxicity and mediates a reactive oxygen species‐independent
induction of apoptosis.
KEY W ORDS
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I N T RO D U CT I O N

cleaning products. AgNP are widely used in medicine for dressing
wounds, in making orthodontic materials, coating of bone prosthesis,

Silver nanoparticles (AgNP) are one of the most crucial metals in

coating of stents or catheters, cleaning surgical equipment and in cer-

nanomedicine/nanotechnology. They have been investigated in the

tain contraceptive devices (Blaske et al., 2013; Correa et al., 2015;

treatment of bacterial diseases and are found to possess a striking anti-

Knetsch & Koole, 2011; Samuel & Guggenbichler, 2004). In recent

microbial activity. AgNP are known to cause oxidative lesion that

years, research involving AgNP has moved beyond investigating its

destroys the bacterial cell wall, facilitating its entry into the cell to bind

antibacterial properties. The possibility of AgNP as an anticancer drug

to sulfhydryl groups of key proteins and bacterial DNA to disrupt crucial

has been the subject of research due to the emergence of drug‐resistant

metabolic processes and halt cell proliferation (Feng et al., 2000;

cancer cells and the discovery that AgNP possess an inherent cytotoxic

Grigor'eva et al., 2013; Wigginton et al., 2010). This has also led to the

effect on cancer cells (Zhang, Liu, Shen, & Gurunathan, 2016).

worldwide commercialization of AgNP in an array of formats with up

With increasing applications of AgNP in consumable products and

to 24% of nanotechnology driven everyday consumer products world-

in medicine there is an increased risk of exposure to the toxic side

wide containing AgNP (Vance et al., 2015). Some of the AgNP‐based

effects of AgNP that may have leached into the environment. Benn

consumable products include but are not limited to food packaging,

and Westerhoff (2008) showed that a sock coated with about

antibacterial creams, coatings in antimicrobial textiles and domestic

1.36 mg of AgNP can release 48% of its coating into water by simply

J Appl Toxicol. 2017;1–12.
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shaking the sock in water or as much as 100% in four consecutive

In this study, AgNP were encapsulated in a liposome made of nat-

washes. AgNP can also be released in the same manner from sham-

ural biosurfactant, dipalmitoyl phosphatidylcholine (DPPC) to improve

poos, toothpaste, detergents and medical apparels (Benn, Cavanagh,

delivery due to increased permeabilization into the target cells. It is

Hristovski, Posner, & Westerhoff, 2010). It has been reported that

hoped that such a system will not only reduce the non‐specific cyto-

AgNP route of entry could be through oral, pulmonary or dermal

toxic effect observed during AgNP treatment, but it may also reduce

routes. Irrespective of the entry route, AgNP induced cell death

the concentration of AgNP required to elicit the expected cytotoxic

through the generation of reactive oxygen species (ROS), increased

response. Subsequently, this may help reduce the development of

DNA damage and impairment of mitochondrial functions (Kang, Jung,

resistant strains to AgNP‐based drug as well as eliminate the release

& Lim, 2012). As such, continuous use of AgNP at these high concen-

of AgNP in large quantities into the ecosystem.

trations comes with a potential danger in the near future. For instance,
inefficient delivery of AgNP to target cells could result in systemic toxicity as it has been previously reported that prolonged biodistribution

2
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of AgNP could result in systemic transport to different tissues particularly to the spleen and liver (Xue et al., 2012). As such, devising ways by

2.1

which low concentrations of AgNP can be efficiently delivered to tar-

Silver nitrate (AgNO3) (CAS no.: 7761‐88‐8), sodium borohydride

|

Materials and reagents

get cells thus becomes pertinent. Generally, the unspecific systemic

(NaBH4) (CAS no.: 16940‐66‐2), DPPC (CAS no.: 63‐89‐8), cholesterol

activities of conventional anticancer drugs are the major limiting factor

(CAS no.: 57‐88‐5), propidium iodide (PI) (CAS no.: 25535‐16‐4) and

in their application as chemotherapeutics. To subvert this negative side

sodium azide (NAN3) (CAS no.: 26628‐22‐8) were all purchased from

effect, encapsulation of drugs in a lipid bilayer has been investigated

Sigma‐Aldrich, Dublin, Ireland. All tissue culture plastics, 96‐well plates,

for improved delivery with promising results (Sercombe et al., 2015).

T75 and T25 flasks were purchased from Thermo Fisher Scientific,

For example, doxorubicin is a potent anticancer drug that inhibits topo-

Dublin, Ireland. Alamar blue (catalogue no. DAL1025), 6‐carboxy‐2′,7′‐

isomerase II preventing accessibility of DNA polymerase to the DNA.

dichlorofluorescein diacetate (carboxy‐DCFDA dye; catalogue no.

Regardless of its potency, there is limitation to the use of doxorubicin

C400) and CellEvent Caspase‐3/7 Green Detection Reagent and SYTOX

in cancer treatment due to the negative side effects following its

AADvanced Dead Cell Stain (catalogue no. C10740) Calcein‐AM dye

administration such as alopecia, hepatotoxicity, cardiotoxicity and

(lot no. 1475337) were all purchased from Life Technologies, through

nephrotoxicity (Tacar, Sriamornsak, & Dass, 2013). However, liposomal

Biosciences Ltd., Dublin, Ireland.

encapsulation of doxorubicin has been shown to improve its delivery in
addition to alleviating the negative side effects of the drug, reducing
the required concentration to achieve cell death (Brown & Khan,
2012; Camacho et al., 2016; Souto et al., 2016).
Liposomes like many other NPs have unique characteristics that
make them efficient drug delivery vehicles. They are suitable for
transporting both hydrophobic and hydrophilic molecules; the lipid

2.2

|

Silver nanoparticle synthesis

AgNPs were produced by a borohydride reduction of silver nitrate as
detailed in Equation 1 below,
AgNO3ðaqÞ þ NaBH4ðaqÞ ➔ Ag0 ðsÞ þ ½ B2 H6ðgÞ þ ½ H2ðgÞ þ NaNO3ðaqÞ
(1)

layer of liposomes can entrap hydrophobic drugs due to hydrophobic
interactions between the fatty acid chains and the drug while the
aqueous core of the liposome can also hold hydrophilic drugs (Bozzuto
& Molinari, 2015). In general, liposomes are often prepared from phospholipids, which then form the outer layer of the nanostructure that
can be similar to the lipid bilayer of the cell membrane. The lipid layer
of liposomes aids the passive transport of the liposome and its associated content into the cell. This prevents the requirement of membrane
channels or pumps normally controlling the entry of charged or polar
molecules such as peptides, metals and synthetic compounds that
can be encapsulated in the lipid vesicle. These attributes allow for dose
intensification of compounds that are encapsulated within the lipo-

Briefly, a 1 mM solution of AgNO3 and 2 mM solution of NaBH4
were prepared in ultrapure grade distilled water. To prevent agglomeration of the AgNP during the reduction process, the reaction was carried
out at low temperature; 30 ml of NaBH4 was added to an Erlenmeyer
flask placed in an ice bath and stirred at 350 rpm for 30 minutes to equilibrate. At a drop per second rate, 6 ml of AgNO3 was added to the
NaBH4 solution under constant stirring. After all the AgNO3 had been
added, the stirring was stopped and the flask taken out of the ice bath.
To prevent further agglomeration of the AgNP the solution was placed
back on the stirrer and stirred until room temperature was achieved. The
resulting golden yellow solution was stable at 4°C.

some while limiting any negative side effects associated with excess
free drug present in a non‐liposome delivery method (Silverman, Reynolds, & Deitcher, 2013). Liposomes have controllable sizes and their
surface properties are easily modified in the synthesis process and

2.3 | X‐ray diffraction and energy dispersive X‐ray
analysis of silver nanoparticle

can be tailored to any functional delivery requirements. These proper-

Powdered X‐ray diffraction (XRD) characterization of AgNP was con-

ties coupled with an enhanced permeability and retention effect

ducted with a Philips diffractometer (Philips Inc., Westborough, USA)

in vivo, increases their ability to accumulate in a tumour microenviron-

using a monochromatic Cu‐Kα1 radiation source (λ = 1.5406 Å) oper-

ment, which is typically composed of leaky vessels and abnormal cell

ated at 40 keV, 30 mA and a 2θ angle pattern. The scanning was car-

junctions (Nehoff, Parayath, Domanovitch, Taurin, & Greish, 2014;

ried out in the 20° to 80° region and the crystalline structure was

Xing, Hwang, & Lu, 2016).

analysed by comparing the obtained result with that of the Joint

YUSUF
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L‐glutamine

Committee on Powder Diffraction Standards library. Energy dispersive

1640 media containing 2 mM

X‐ray of AgNP was carried out by drop casting 100 μl of AgNP on a sil-

mented with 10% fetal bovine serum and incubated at 37°C, 95%

icon (Si) wafer and analysed using a Hitachi SU‐70 (Hitachi, Tokyo,

humidity and 5% CO2.

Japan) Oxford Instruments 50 mm2 X‐Max silicon drift EDS detector
operated at 20 keV.

(Sigma‐Aldrich) supple-

For particle exposure, cells were seeded in to a 96‐well plate at a
density of 1 × 104 cells in 100 μl of culture media for a 24 and 48 hour
time period. A minimum of three independent experiments were con-

2.4
Liposome preparation and encapsulation of
silver nanoparticle
|

ducted and for each independent experiment, six replicate wells were
employed per concentration per plate. The cells were then treated with
un‐encapsulated (AgNP) and Lipo‐AgNP after seeding. A positive kill

Liposomes were prepared with a combination of DPPC and cholesterol
via modification of a dehydration–rehydration technique originally
reported by Mugabe, Azghani, and Omri (2006). Initially, DPPC and cho-

control, a 10% (v/v) dimethyl sulfoxide solution was prepared in
serum‐free media to treat the cells while a negative control of unexposed cells was also incorporated on to the plate for both AgNP‐ and

lesterol were dissolved in 5 ml chloroform and the solution was mixed

Lipo‐AgNP‐exposed cells. An additional positive control was performed

until clear. It was then dried in a vacuum oven at 52°C overnight (above

for THP1 cells exposed to 0.325–5 μg ml–1 Ag+ solution, prepared by

melting temperature of DPPC). The resultant lipid cake was rehydrated
in distilled deionized water (ddH2O) at 60°C in a shaker. After the lipid

dissolving corresponding amount of AgNO3 in ddH2O, to test the possible influence of AgNP ionization into Ag+ on its cytotoxic effect.

was rehydrated, an AgNP solution was added to make a final lipid concentration of 1 mg ml–1 of DPPC and 0.23 mg ml–1 of cholesterol to give
a 7:3 molar ratio (Briuglia, Rotella, McFarlane, & Lamprou, 2015). The

2.8

Cell viability
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solution was then placed in the shaker at 60°C for another 20 minutes

Cellular viability was evaluated with the Alamar Blue assay (AB). Briefly,

after which it was vortexed and extruded through a 100 nm Nanosizer

a 10% (v/v) AB solution in serum‐free media was prepared and kept

polycarbonate extruder (TTScientific, Knoxville, USA). The resulting col-

warm in a water bath at 37°C. The plate containing treated cells was

loidal mixture was stored at 4°C before use.

centrifuged in a Heraeus Megafuge 16R (Thermo Fisher) at 500 g and
20°C for 5 minutes and the exposure media removed after which

2.5 | Estimating encapsulation efficiency of the
liposome

100 μl of the 10% AB solution was added to each well. The plates were
then incubated for 3 hours after which the resulting fluorescence of the
converted AB dye was measured at 540 and 595 nm excitation and

To estimate the encapsulation efficiency, Lipo‐AgNP were centrifuged

emission wavelengths respectively using SpectraMax® M3 Multi‐

at 30 000 g for 1 hour and the supernatant harvested. The supernatant

Mode Microplate Reader and compared to the relative controls.

was then analysed by atomic absorption spectrophotometry to estimate the concentration of silver in the solution. The encapsulation efficiency (E) of the liposome was then calculated using the formula below:

2.9

Reactive oxygen species assay

|

ROS generation in the THP1 cells because of particle exposure was
Total AgNP added to liposome−AgNP in supernatant
E¼
× 100 (2)
Total AgNP added to liposome

measured with a carboxy‐DCFDA assay. In the assay carboxy‐DCFDA
a non‐fluorescent dye is metabolized by esterase into H2DCFDA,
which is further oxidized by ROS generated in the cell to a green fluo-

2.6 | Scanning and scanning transmission electron
micrograph analysis

rescent DCFDA dye. To quantify ROS generation, the THP1 cells were
seeded into a T75 flask at 5 × 105 cells ml–1 in RPMI media containing
2% fetal bovine serum and the cells were loaded with 10 μM of

Scanning electron micrograph (SEM) micrographs were obtained for all

carboxy‐DCFDA dye and incubated for 30 minutes under normal cul-

AgNP and liposomal AgNP (Lipo‐AgNP) using a Hitachi SU‐6600 field

ture condition. The loaded cells were then centrifuged at 300 g for

emission SEM (Hitachi, Maidenhead, UK) at an accelerating voltage

5 min and the medium containing excess carboxy‐DCFDA was

of 25 kV and working distance of 8 mm. Before SEM analysis, 5 μl of

removed. The loaded cells were then washed twice in warm sterile

each sample was drop‐cast on to a 5 × 5 mm pure silicon wafer sub-

phosphate‐buffered saline (PBS) and then re‐suspended in normal cul-

strate (Ted Pella Inc., Redding, California, USA) 24 hours before

ture media. The cells were then seeded into Corning 96‐well solid

obtaining micrographs and allowed to air dry. Before scanning trans-

black plates (VWR, Dublin, Ireland) at 2 × 105 cells ml–1 and treated

mission electron micrograph (STEM) analysis, 3 μl of each sample

with AgNP or Lipo‐AgNP at 0.3 μg ml–1. ROS generation was then

was drop‐cast on to a carbon formvar copper grid (Agar Scientific

quantified by the fluorescence of the oxidized carboxy‐DCFDA, by

Ltd., Stanstead, UK) 24 hours before obtaining micrographs and

monitoring the dye emissions at 535 by 485 nm excitation on a

allowed to air dry.

Spectramax M3 multiplate reader, using multi‐well scan at five different points per well.

2.7

|

Cell culture and exposure

THP1 (ATCC®; TIB‐202™) a suspension line derived from a human

2.10

|

Flow cytometry

peripheral blood monocyte from an acute monocytic leukaemia

For flow cytometry analysis THP1 cells were seeded and cultured in

patient, was used for this study. THP1 cells were cultured in RPMI‐

T25 flasks at 2 × 105 cells ml–1 and were subsequently treated with

4

YUSUF

Lipo‐AgNP and AgNP for 24 hours. After exposure, cells were harvested into 15 ml tubes and were centrifuged at 300 g for 5 minutes

TABLE 1

Size and zeta potential of AgNP, lyophilized and extruded
Lipo‐AgNP in ddH2O and RPMI‐1640 media

at 22°C to form pellets. The pellets were resuspended in 2 ml

In ddH2O
Intensity PSD

prewarmed 1× PBS and centrifuged as above and the process was
repeated. Before staining the pellet was finally resuspended in 1 ml

AgNP

DLS (nm)
Zeta (mV)
PDI

21.14 ± 9.48
–26.50
0.230

Extruded
Lipo‐AgNP

DLS (nm)
Zeta (mV)
PDI

140.1 ± 47.49
–31.9
0.105

binding buffer a 0.1% NaN3 and 1% bovine serum albumin solution
in 1× PBS.
For live–dead staining the cells were double stained by adding 5 μl
of 1 μM calcein‐AM stain and 10 μl of 10 μg ml–1 PI. The cells were
then incubated in the dark at room temperature for 20 minutes and
analysed with a BD Accuri C6 flow cytometer (BD, Oxford, UK).
For the cell cycle analysis, cells were harvested as above and

ET AL.

In media
Intensity PSD
79.15 ± 66.67
–7.90
0.566
138.9 ± 54.93
–0.61
0.421

AgNP, silver nanoparticle; ddH2O, distilled deionized water; DLS, dynamic
light scattering; Lipo‐AgNP, liposomal silver nanoparticle; PDI, polydispersity index; PSD, particle size distribution.

rinsed in warm sterile PBS. The cells were then fixed with ice‐cold
70% ethanol. After ethanol fixation, the cells were incubated at 4°C

compared to dispersion in RPMI‐1640 media. However, no sedimenta-

for up to 4 hours. Before any staining, the cells were washed twice

tion was observed for the AgNP when dispersed in RPMI‐1640 likely

in PBS and centrifuged at 800 g for 5 minutes and the cell pellet

due to the concentration used. There was a measurable drop in zeta

–1

treated with 50 μl of a 100 μg ml

ribonuclease A to ensure only

potential values for AgNP (zeta = –26.5 to –7.9 mV) and Lipo‐AgNP

DNA was stained. The cells were then stained with 400 μl of 50 μg

(zeta = –31.9 to –0.61 mV) when dispersed in ddH2O to RPMI‐1640

ml–1 PI and incubated for 10 minutes before analysing using BD Accuri

media, indicating a less stable NP in RPMI‐1640 media.

C6 flow cytometer.

As shown in Figure 1(B), energy dispersive X‐ray analysis con-

Finally for Caspase3/7 analysis, as before the THP1 cells treated

firmed the presence of elemental AgNP in the sample as the strong

with AgNP and Lipo‐AgNP were harvested and centrifuged at 300 g

peak at 3 keV. The other peaks observed correspond to other elements

for 5 minutes to remove exposure solutions. As a positive control,

due to sample preparation, the substrate (Si wafer) and carbon tab for

THP1 cells were exposed to 1 μM solution of doxorubicin, which is a

conductive support. Result from XRD characterization of AgNP is

known activator of the executioner caspases. The cells were washed

shown in Figure S1(C). The XRD pattern shows four main peaks for

in PBS once and then resuspended in binding buffer. The cells were

AgNP at 2θ values of 38.30°, 44.55°, 64.60° and 77.55°, which corre-

then stained with 500 nM CellEvent caspase 3/7 detection reagent

sponds to (111), (200), (220) and (311) planes respectively for the face‐

and incubated at 37C for 30 minutes. The cells were then stained with

centred cubic structure of metallic silver. This pattern is in agreement

1 μM SYTOX AAdvanced dead cell stain and incubated for 5 minutes

with that of the Joint Committee on Powder Diffraction Standards file

before being analysed on a BD Accuri C6 flow cytometer.

no. 04‐0783 confirming the crystalline structure of the synthesized

2.11

Reséndez, 2016). The average size of synthesized AgNP was estimated

AgNP (Luna, Barriga‐Castro, Gómez‐Treviño, Núñez, & Mendoza‐
|

Statistical analysis

by the Debye–Scherrer's equation (Equation 3)
Statistical analysis was carried out using GraphPad Prism version 7.
Data were analysed by two‐way analysis of variance followed by
Tukey's multiple comparison tests to detect significance in effects
between exposure groups. Statistically significant differences in tests
were indicated for P < 0.05.

D¼

0:9λ
βCos θ

(3)

Where D is the size of AgNP crystal in nm, λ is the wavelength of
the diffractometer, β is the full width at half maximum intensity and θ
is the Bragg angle. Based on the equation, the size of AgNP crystal was

3

RESULTS

|

estimated to be 18.7 nm, which was similar to that of the average size
as determined by DLS measurement of 21.24 nm.

3.1

|

Particle characterization

SEM and STEM were used to evaluate the morphology of the NPs
and to estimate the size distribution values of the NPs in dry state. The

A summary of the synthesized NPs characterization using DLS is

STEM analysis of AgNP showed all particles produced were spherical

shown in Table 1 for different dispersion environments. DLS analysis

with an average size of 14.3 ± 1.9 nm, which is similar to that estimated

of AgNP showed a dramatic increase in mean particle size when dis-

by the XRD analysis (Figure S1A). SEM analysis of Lipo‐AgNP showed

persed in RPMI‐1640 media when compared to dispersion in ddH2O

spherical and uniformly extruded vesicles while the contrasting image

from 21.24 to 79.15 nm respectively. This increase in size was accom-

of the STEM showed encapsulation of the AgNP in the liposome with

panied by a change in colour of the AgNP when dispersed in RPMI‐

an average size of 82.73 ± 29.23 nm (Figure 2A,B), which displays size

1640 from the usual golden yellow colour to dark grey. In contrast,

values less than the DLS values, which considering the hydrodynamic

there was no significant change in the mean particle size of Lipo‐AgNP

radius of the NPs was expected (Table 1). To confirm the encapsula-

when dispersed in RPMI‐1640 compared to ddH2O and no colour

tion, DLS values of both AgNP before and after encapsulation were

change when dispersed in RPMI‐1640 media. There was an observable

overlaid to determine if any unencapsulated AgNPs were present in

increase in polydispersity index (PDI) of the AgNP (PDI = 0.23–0.566)

the test sample (Figure 2C). As expected, there was no overlap in the

and the Lipo‐AgNP (PDI = 0.105–0.421) when dispersed in water

size values showing successful encapsulation of AgNP.

YUSUF
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FIGURE 1

Silver nanoparticles characterisation by scanning transmission electron micrograph, energy dispersive X‐ray and X‐ray diffraction.
Characterization of nanoparticles showing (a) scanning transmission electron micrograph, (b) energy dispersive X‐ray analysis of silver
nanoparticles on a silicon wafer and (C) X‐ray diffraction pattern of silver nanoparticles synthesized by chemical reduction method

FIGURE 2

Lipo‐AgNP characterization by scanning electron micrograph/scanning transmission electron micrograph and dynamic light scattering.
Characterization of nanoparticles showing (a) scanning transmission electron micrograph, (b) scanning electron micrograph and (c) superposition of
AgNP dynamic light scattering analysis before and after encapsulation in extruded liposome. AgNP, silver nanoparticle; Lipo‐AgNP, liposomal silver
nanoparticle

3.2

|

Encapsulation efficiency

was between 85% and 89% of the total AgNP added before
encapsulation.

Encapsulation efficiency of Lipo‐AgNP was estimated based on Equation 2. A 10 μg ml–1 AgNP solution (representing total AgNP added)
was used to rehydrate the lipid film and the liposome was prepared

3.3

|

Cellular viability study

as described above. The encapsulation efficiency of the different

The cell viability of THP1 cell line was evaluated by AB assay. The

Lipo‐AgNP preparations (Lipo‐AgNP L1–L3) are shown in Table 2

assay evaluates the ability of metabolically active cells to reduce

6
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TABLE 2

Encapsulation efficiency of Lipo‐AgNP

ET AL.

To verify the AB findings, the levels of THP1 cell viability after

Lipo‐
AgNP‐L1

Lipo‐
AgNP‐L2

Lipo‐
AgNP‐L3

exposure were monitored by flow cytometry. Flow cytometry is a sin-

Total AgNP (μg ml )

10.00

10.00

10.00

exact viability levels in the exposures when compared to the AB assay.

AgNP in supernatant
(μg ml–1)

1.13

1.50

1.43

THP1 cell death was evaluated by initially staining the cells with

88.7%

85.0%

85.7%

–1

gle cell analysis method and because it gives a better indication of the

calcein‐AM and PI 24 hours after being exposed to 0.625 μg ml–1 of

Encapsulation efficiency

AgNP, silver nanoparticle; Lipo‐AgNP, liposomal silver nanoparticle.

AgNP and Lipo‐AgNP. Compared to an unexposed control as with
the previous viability measurements, 10% dimethyl sulfoxide medium
solution was used as a positive control.

resazurin, a non‐fluorescent blue dye to resorufin, a pink fluorescent

From the results obtained, there was no significant difference in

product. Reduction of resazurin is done by both mitochondrial and

the percentage of live cells between the control (98.35%) and AgNP‐

cytoplasmic reducing agents such as NADPH, NADH, FMNH and

treated cells (98.55%) after 24 hours. However, we discovered a highly

FADH, and as such the assay gives a broad indication of cellular viabil-

significant difference in the percentage of live cells treated with

ity (Rampersad, 2012). THP1 cells were exposed to varying concentra-

Lipo‐AgNP (66.75%) compared with AgNP (Figure 4). In both control‐

tions of AgNP and Lipo‐AgNP (0.3–5 μg ml–1) for 24 and 48 hours. To

unexposed and AgNP‐treated cells, only 0.5% cell death was observed

evaluate possible ionization of AgNP into Ag+, we exposed THP1 cells

after 24 hours. Contrarily, Lipo‐AgNP treatment induced cell death in

+

to same concentration of Ag for 24 hours. At 24 hours, there was sig-

32.5% of THP1 cells, a highly significant increase in cell death com-

nificant reduction in THP1 cell viability treated with 2.5 μg ml–1 of

pared with both control‐unexposed and AgNP‐treated THP1 cells after

Lipo‐AgNP and cells treated with 5 μg ml–1 AgNP and Lipo‐AgNP

24 hours. This result suggests Lipo‐AgNP is capable of inducing cell

when compared with the unexposed control cells (Figure 3A). Interest-

death at lower dose than that established by AB assay.

+

ingly, the cytotoxic effect of Ag was threefold that of AgNP, showing
a highly significant reduction in THP1 cell viability at concentrations
0.625–2.5 μg ml–1 and twofold reduction at 5 μg ml–1 after 24 hours.
Ag+ induced significant reduction in THP1 cell viability when compared
with AgNP at concentrations ≥0.625 μg ml–1. The IC50 of AgNP, Lipo‐
AgNP and Ag+ at 24 hours was estimated to be 4.991, 3.045 and
0.3226 μg ml–1 respectively. At 48 hours, there was a significant
reduction in cell viability for all exposure groups and concentration
when compared to control. Interestingly, it induced a significant reduction in THP1 cell viability by 2.5 μg ml–1 of Lipo‐AgNP compared to the
AgNP at the same concentration (Figure 3B). Cell viability for Ag+ was
not carried out at 48 hours as ≤20% cell viability was already observed
at 24 hours. To ensure the cytotoxic effect of Lipo‐AgNP was due to
the encapsulated AgNP and not the liposome, we exposed THP1 cells
to empty liposome at the same concentrations with 1.25 and 2.5 μg
ml–1. THP1 cell viability after 24 hours' exposure showed no significant
difference when compared with unexposed THP1 cells (Supporting
information, Figure S1).

FIGURE 4 Lipo‐AgNP induced THP1 cell death. Control THP1 cells,
and cells treated with 0.625 μg ml–1 of AgNP and Lipo‐AgNP and
10% DMSO were incubated for 24 hours and were washed in
phosphate‐buffered saline before staining with 10 μg ml–1 propidium
iodide and 10 nM calcein‐AM. Data represent mean percentage ±
standard error of the mean (n = 3). ****P < 0.0001. AgNP, silver
nanoparticle; DMSO, dimethyl sulfoxide; Lipo‐AgNP, liposomal silver
nanoparticle

Cell viability of (a) AgNP, Lipo‐AgNP and Ag+ exposed cells at 24 hours and (b) AgNP and Lipo‐AgNP at 48 hours as determined by the
Alamar blue assay. Data are expressed as a percentage of three independent experiments ± standard error of the mean of the four individual
experiments and relative to a two‐dimensional culture control. Statistically significant differences between the exposed viability responses and that
of the control cultures are denoted by *P < 0.05, **P < 0.01, ****P < 0.0001. AgNP, silver nanoparticle; Lipo‐AgNP, liposomal silver nanoparticle

FIGURE 3
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Cell cycle analysis

THP1 cells were exposed to 0.625 μg ml–1 of AgNP and Lipo‐
AgNP while unexposed cells were used as controls. Cell cycle analysis after 24 hours of exposure showed that exposure of THP1
cells to both AgNP and Lipo‐AgNP did not affect the cell cycle progression from G1 to S phase and there was no significant difference
between the exposed cells to control‐unexposed cells. Exposure of
THP1 cells to Lipo‐AgNP resulted in 21.1% cells in the G2/M phase
of the cell cycle. As expected, AgNP treatment did not show any
effect on cells in the G2/M phase having 32.65% cells comparable
to the 30.85% unexposed‐control cells in G2/M phase. Interestingly,
it was found that Lipo‐AgNP treatment resulted in 8.4% cells in the
sub‐G1 phase compared with 0.65% and 0.8% cells for both unexposed‐control and AgNP‐treated cells respectively (Figure 5). This
indicated that Lipo‐AgNP at low doses caused DNA fragmentation,
which was evident by the characteristic of sub‐G1 peak. The per-

THP1 cell lines were loaded with 10 μM 6‐carboxy‐2′,7′‐
dichlorofluorescein diacetate dye for 20 minutes. After which they
were exposed to 0.3 μg ml–1 AgNP and Lipo‐AgNP for up to 4 hours.
Control value was set as baseline for all time points and represented as
mean ± standard error of the mean (n = 3). AgNP, silver nanoparticle;
Lipo‐AgNP, liposomal silver nanoparticle; ROS, reactive oxygen
species
FIGURE 6

centage of cells in the G0/G1 and S phases remained the same in
all groups, suggesting no apparent effect of treatment on cells in
all exposure groups

3.5

|
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Caspase activation

ROS and DNA damage are known to be indicators of apoptosis and to

Reactive oxygen species induction

verify this was the mechanism of action utilized by Lipo‐AgNP, the

DNA fragmentation is one of the consequences of ROS generation

CellEvent Caspase‐3/7 Green Detection Reagent and SYTOX

before apoptosis. To determine if low‐dose Lipo‐AgNP was inducing

AADvanced Dead Cell Stain were employed. THP1 cells exposed to

the generation of ROS at sufficient levels to induce DNA damage,

0.625 μg ml–1 of AgNP and Lipo‐AgNP were stained after 1, 4 and

ROS levels were monitored in THP1 cells exposed to 0.3 μg ml

–1

24 hours of exposure. The result showed basal caspase activities at 1

Lipo‐AgNP at varying time points indicated in Figure 6 alongside an

and 4 hours in all exposure groups with an average of 2% of the total

unexposed‐control and uncapped AgNP to plot ROS generation as a

cell population exhibiting caspase activities. After 24 hours of expo-

function of time. From 30 minutes to 5 hours, there was an average

sure, the level of caspase activation remained the same for control‐

of 1.5‐fold induction of ROS in cells exposed to 0.3 μg ml–1 of AgNP

unexposed cells and AgNP‐treated cells. Conversely, 33% of total

compared to control cell ROS. Cells exposed to the same concentra-

THP1 cells exposed to Lipo‐AgNP were positive for caspase activation

tion of Lipo‐AgNP showed mild suppression of ROS induction up to

at 24 hours (Figure 7). This result suggested the cell death observed in

4 hours, which significantly increased to approximately threefold of

Lipo‐AgNP exposed cells was likely a consequence of caspase‐3/7

control ROS at 24 hours. This indicates that ROS generation was not

activation.

responsible for the observed cell death in THP1 cells exposed to
0.3 μg ml–1 of Lipo‐AgNP.

FIGURE 5

Lipo‐AgNP treatment induced DNA fragmentation: THP1
cell lines were treated with 0.625 μg ml–1 of Lipo‐AgNP and AgNP
while unexposed cells and 10% dimethyl sulfoxide‐treated cells were
used as controls. Data represent mean percentage ± SEM (n = 3), *P <
0.05. AgNP, silver nanoparticle; Lipo‐AgNP, liposomal silver
nanoparticle

FIGURE 7 Lipo‐AgNP activates caspase‐dependent apoptosis in
THP1 cells after 24 hours. THP1 cells that were unexposed, treated
with 0.625 μg ml–1 of AgNP, 0.625 μg ml–1 of Lipo‐AgNP and 1 μM
doxorubixin were stained with 500 nM CellEvent™ for 30 minutes and
co‐stained with 1 μM Sytox AADvanced during the last 5 minutes.
Data are represented as mean ± standard error of the mean (n = 3),
****P < 0.0001. AgNP, silver nanoparticle; Dox, doxorubixin; Lipo‐
AgNP, liposomal silver nanoparticle
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the hydrodynamic radius, which includes the aqueous layer, tends to
be slightly larger than dry particle radius. The XRD pattern analysis

Currently AgNPs are the main active ingredient in multiple nano‐

using the Debye–Scherrer equation estimated a size of 18.7 nm and

enabled commercial products worldwide, primarily due to their antimi-

peak pattern that is characteristic of a face‐centred cubic crystalline

crobial activities. Despite this, several studies have investigated and

structure. This finding is in agreement to those of other studies further

identified the cytotoxicity related hazards associated with AgNP

confirming the sample as metallic silver (Anandalakshmi, Venugobal, &

(Connolly et al., 2015; Nowrouzi et al., 2010; Zhang, Wang, Chen, &

Ramasamy, 2016; Bindhu & Umadevi, 2015). However, there are two

Chen, 2014). Interestingly, the increasing investigation of AgNP cyto-

peaks around 26° and 30.7°, which are not characteristic of silver.

toxicity has now moved beyond antibacterial applications and recent

These peaks may be generated by the NaBH4 reducing agent used in

studies are investigating the potential of AgNPs as anticancer drugs.

chemical reduction of AgNO3 and it is similar to those reported in

This shift is partially due to the evolution of multidrug‐resistant cancer

other studies for NaBH4 (Agnihotri, Mukherji, & Mukherji, 2014; Su,

cells similar to that of antibiotic‐resistant bacteria. Foldbjerg et al.

Lu, Wang, & Huang, 2012).

(2012) noted that AgNP at an EC20 of 12.1 μg ml–1 showed potential

Several studies have noted particle size changes of AgNP in cell

anticancer properties such as induction of ROS, modulation of cell divi-

culture environments, as such the size distributions of AgNP and

sion and growth regulatory gene expressions such as cyclin B1 and his-

Lipo‐AgNP in culture media were monitored and compared to those

tone H1B and the arrest of cells in the G2/M phase. Lin et al. (2014)

in water. An AgNP size increase from 21.14 to 79.15 nm was observed

–1

showed that 10 μg ml

of AgNPs produced enhanced cytotoxicity in

in media compared to when dispersed in water. This size increase was

HeLa and B16 mouse melanoma cell lines that have undergone chemo-

presumed to be an indication of NP agglomeration in the solution. In

therapeutic or genetically induced autophagy inhibition by preventing

contrast, this was not the same for Lipo‐AgNP where there was a slight

formation of anti‐apoptotic autophagosomes normally induced by

reduction in recorded sizes (140.1 nm in water and 138.9 nm in media).

AgNP in these cell lines. Asharani et al. (2012) showed that 400 μg

Previous studies have reported an increase in AgNP size in culture

ml–1 of AgNP induces activation of γH2AX foci, suppresses expression

media and this increase in size has been proposed to be due to an asso-

of key cell cycle proteins such as p21, p53 and cyclin B, and induces

ciation of AgNP with proteins (Hansen & Thunemann, 2015;

the expression of DNA damage response genes RPA1 and FEN1. Sev-

Mukherjee, O'Claonadh, Casey, & Chambers, 2012; Murphy, Sheehy,

eral other studies evaluating the antibacterial properties and mecha-

Casey, & Chambers, 2015; Shannahan et al., 2013). The interaction

nism of action of AgNP have shown the minimum inhibitory

of AgNP with protein in culture media was most likely prevented by

concentration of AgNP from 10 μg ml–1 to as high as 180 μg ml–1

Lipo‐AgNP due to the presence of the protective lipid layer, preventing

for different bacteria strains (Amato et al., 2011; Bao et al., 2015;

the encapsulated AgNP from directly interacting with biomolecules in

Guzman, Dille, & Godet, 2012; Hsueh et al., 2015; Maiti, Krishnan, Bar-

the milieu of the culture media. Additionally, there was an increase

man, Ghosh, & Laha, 2014). None the less, all of these studies have

in PDI values for AgNP in both water and RPMI‐1640, the difference

investigated AgNP activities at high concentrations, which are likely

in these PDI values for AgNP was higher than that of Lipo‐AgNP.

to be detrimental to human health, thus limiting the potential thera-

PDI value increases indicate an increased non‐uniformity of the NPs

peutic applications. Hence, this necessitates development of delivery

when they were dispersed into the culture media. These findings sug-

systems capable of delivering AgNPs intracellularly at a lower concen-

gest encapsulation and formation of the Lipo‐AgNP suppresses the

tration to achieve the desired pharmacological response.

changes in morphology of AgNP in culture media and ultimately

In this study, an in‐house synthesized AgNP was encapsulated to

improves their stability in comparison to standard AgNP.

improve the in vitro delivery of the AgNP to enhance their in vitro

After dispersion, cellular viability levels of THP1 cells exposed to

effects and simultaneously reduce the dose required. NPs are found

varying concentration of AgNP and Lipo‐AgNP (0.3–5 μg ml–1) for 24

in bodily tissues and fluid after entering the body through different

and 48 hours were monitored with the AB assay. The results showed

routes such as oral, intravenous, transdermal or inhalation (Yildirimer,

a dose‐dependent reduction in cell viability with a greater level of

Thanh, Loizidou, & Seifalian, 2011). The use of THP1 in the study

cytotoxicity observed for the Lipo‐AgNP‐treated cells. A significant

was to mimic such presence in the blood system because of relocation

THP1 cell viability reduction was observed at 2.5 μg ml–1 Lipo‐AgNP

in a diseased condition and as an enhanced delivery mechanism for

treatment (P < 0.05) and interestingly not for AgNP of the same con-

cancer. There are multiple reports on the effect of NP size on drug

centration after 24 hours. In contrast, there was a significant reduction

delivery and cellular internalization. NPs of larger sizes (<500 nm)

in cell viability of THP1 cells treated with 2.5 μg ml–1 Lipo‐AgNP com-

are, in addition to hepatic uptake, more prone to clearance by the retic-

pared to AgNP of the same concentration at 48 hours (P < 0.0001),

uloendothelial system resulting in reduced bioavailability and pharma-

suggesting Lipo‐AgNP were more cytotoxic than AgNP. AgNP only

cological potential (Alexis, Pridgen, Molnar, & Farokhzad, 2008; Omar

induced significant reduction in cell viability at 5 μg ml–1 and ≥2.5 μg

Zaki, Ibrahim, & Katas, 2015). Both the DLS and SEM/STEM character-

ml–1 at 24 and 48 hours respectively when compared to control. This

ization showed the sizes of the AgNP and Lipo‐AgNP to be below 30

finding is in agreement with those of other studies that investigated

and 200 nm respectively. In general, DLS values were slightly higher

dose‐dependent cytotoxicity of AgNP on different human cell lines.

than that of the SEM values and this was as expected as the DLS is

Jiang et al. (2013) reported significant reduction of Chinese hamster

an intensity measurement that tracks the hydrodynamic radius of the

ovary k1 cell viability at concentrations ≥5 μg ml–1 at 24 hours using

solvated NP while SEM/STEM imaging is a physical snapshot of the

MTT assay. Juarez‐Moreno et al. (2016) in their study reported similar

dry particles with no influence from surrounding solvent. As such,

AgNP IC50 to that of this study in addition to significant reduction in
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cell viability at AgNP concentrations ≥1.25 μg ml–1 for eight different

successfully passed through the G1/S checkpoint replicate their DNA

human cancer cell lines where viability was monitored with the MTT

in preparation for progression into the G2/M phase where they divide

assay. Variations in the cytotoxicity of AgNP in these cell lines could

during mitosis (Takeda & Dutta, 2005). DNA damage in the S

be attributed to the difference in sensitivity of the cell lines to the

phase results in activation of ataxia–telangiectasia‐mutated and

NP but also differences in assays employed to monitor viability. Inter-

ataxia–telangiectasia‐related kinases, which in turn activate CHK2,

estingly, Murphy, Casey, Byrne, Chambers, and Howe (2016) who used

γH2AX and the BRCA genes to slow down replication through abroga-

THP1 cells reported dose‐dependent cytotoxicity of AgNP (50–70 nm

tion of origin firing and signal DNA damage for repair. Increased DNA

size) with significant difference from ≥1.9 μg ml–1. This contrasted

damage, however, results in induction of apoptosis by ataxia–telangi-

with our findings and could be due to polyvinyl pyrrolidine‐coated

ectasia‐mutated, ataxia–telangiectasia‐related and CHK2 activation

AgNP used in the study, which may have its own inherent toxicity.

of p53 (Norbury & Zhivotovsky, 2004; Willis & Rhind, 2009). A popu-

Of course, it may be because of a difference in particle sizes, which

lation in the sub‐G1 upon Lipo‐AgNP exposure was noted and such

have been previously shown to mediate cytotoxicity irrespective

populations are known to be cells with fragmented DNA that are

of capping agent used (Gliga, Skoglund, Wallinder, Fadeel, &

undergoing or have undergone apoptosis. A genomic DNA

Karlsson, 2014).

fragmenting effect of AgNP has indeed been previously demonstrated

AgNP ionization into Ag+ has been widely proposed as its mecha-

by Awasthi et al. (2013) and may be occurring in this study after expo-

nism of action in inducing cytotoxicity (Hsueh et al., 2015; Lansdown,

sure to Lipo‐AgNP. The proportion of cells observed in the sub‐G1

+

2010). As such, we investigated the cytotoxicity of Ag on THP1 cells

recorded because of Lipo‐AgNP exposure matches the reduction in

and our findings indicate that Ag+ at concentrations between 0.625

the G2/M phase. This may indicate the cells were forced out of the cell

and 2.5 μg ml–1 reduced THP1 cell viability by more than threefold

cycle due to the increased DNA damage because of Lipo‐AgNP expo-

while twofold reduction in cell viability was observed for THP1

sure and died via apoptotic mechanisms.

–1

exposed to 5 μg ml

+

Ag when compared with AgNP at the same con-

The cell induces apoptosis for many reasons, one of which is to

centrations. This finding is in agreement with that of Foldbjerg et al.

maintain genome integrity by killing cells with a high amount of DNA

(2009) who used flow cytometric analysis to determine viability of

damage. ROS induction is often used to activate the signalling cascade

THP1 cells after exposure to AgNP and Ag+. Their findings showed

that results in apoptotic induction in such cells. ROS are known to dis-

at least a twofold reduction in THP1 cell viability after exposure to

rupt the mitochondrial membrane that results in the release of cyto-

≥0.625 μg ml–1 Ag+. There was a similar concentration‐dependent

chrome c. Release of cytochrome c activates the proapoptotic Bcl2

cytotoxicity profile for both AgNP and Ag+ although Ag+ had higher

proteins Bax and Bak, which in turn activate executioner caspases 3

toxicity. Taken together, ionization of AgNP into Ag+ is likely responsi-

and 7 (Quast, Berger, & Eberle, 2013). There are reports in the litera-

ble for the cytotoxic effect of AgNP. The lower cytotoxic effect of

ture indicating that AgNPs cause apoptosis by inducing increased gen-

AgNP may be because of its slow ionization rate as it has been

eration of ROS. Indeed Kang et al. (2012) and Foldbjerg, Dang, and

reported that the AgNP ionization rate correlates with its concentra-

Autrup (2011) reported a dose‐ and time‐dependent ROS‐induced

tion (Maurer‐Jones, Mousavi, Chen, Buhlmann, & Haynes, 2013). This

apoptosis in dendritic cell line (DC2.4) and A549 lung cell lines respec-

is also supported by the reduction in Ag+ cytotoxic effect to twofold

tively because of AgNP exposure. Awasthi et al. (2013) also reported a

relative to that of AgNP at 5 μg ml–1. This may be consequent upon

dose‐dependent ROS generation and induction of apoptosis in Chi-

increased ionization of AgNP with increased concentration. In addition,

nese hamster ovary cell lines. To monitor if this was occurring here

the steady reduction in THP1 cell viability after 48 hours of exposure

because of the Lipo‐AgNP exposure, ROS generation was monitored

–1

to 0.625–2.5 μg ml

in THP1 cell lines. The cells were treated with a low concentration of

of AgNP also supports this notion.

To verify the results of the AB assay, flow cytometry, which is a

AgNP and Lipo‐AgNP (0.3 μg ml–1) for up to 4 hours to evaluate the

more sensitive technique, was employed to evaluate cell viability after

onset of ROS generation. It was noted that AgNP exposure did induce

exposure to THP1 cells with AgNP and Lipo‐AgNP. Calcein‐AM and PI

ROS, but non‐significant levels of ROS with respect to the controls,

–1

staining of THP1 cells after 24 hours of treatment with 0.625 μg ml

most likely because the concentrations considered were not cytotoxic

Lipo‐AgNP showed induction of a significant amount of death in the

to the cells. In contrast to the previous studies, this study showed that

cells (P < 0.0001). Conversely, AgNP treatment showed a comparable

Lipo‐AgNP did not induce ROS generation to cause THP1 cell death. In

outcome to control‐unexposed cells with little or no cell death

fact, there was an observable suppression of ROS induction. The vari-

observed, verifying the AB assay results that the Lipo‐AgNP exhibited

ation in these studies can likely be due to several factors, which include

a higher level of cytotoxicity than AgNP alone.

but are not limited to differences in cell lines, size and surface charac-

Several studies have shown that AgNP can initiate cell cycle arrest

teristics of the AgNP used.

at different phases of the cell cycle including the G0/G1, S and G2/M

The literature indicates cell death because of AgNP exposure is

phases (Asharani et al., 2012; De Matteis et al., 2015; Eom & Choi,

typically due to ROS generation with subsequent DNA damage to

2010). As such, the effect of low‐dose Lipo‐AgNP on the THP1 cell

the cells followed by apoptosis. However, findings of this study sug-

cycle was monitored. Our findings showed normal progression of

gested ROS was not involved in the induction of observed cell death

THP1 cells from the G1 to the S‐phase for all exposure and control

when studying the Lipo‐AgNP. One of the downstream factors acti-

groups. On the contrary, Lipo‐AgNP exposure resulted in a significant

vated by p53 signalling after sensing DNA damage is caspase 3. Differ-

reduction in G2/M cell population compared with the control and

ent studies have shown that activation of p53 in response to DNA

AgNP‐treated cells (P < 0.05). In the S‐phase, cells that have

damage results in p53 transcriptional upregulation of Puma and Noxa,
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inhibitors of Bcl‐2, Bcl‐xl and Mcl‐1. Inhibition of these Bcl proteins

can cause exaggerated and unscheduled inflammatory responses,

result in Bax and Bak activation, which ultimately result in cytochrome

which may promote tumour development (Vakkila & Lotze, 2004). As

c release and activation of the executioner caspases (Ashkenazi, 2008).

such, these secondary effects can be prevented by coating the AgNP

To explore the possibility of ROS‐independent induction of apoptosis,

surface in a protective layer as demonstrated in this study.

activation of caspases 3/7 in THP1 cells treated with the same low‐
dose AgNP and Lipo‐AgNP at 1, 4 and 24 hours to monitor onset of
activation was investigated. For all cell groups, there was no significant
activation of caspases 3/7 at 1 and 4 hours. On the other hand, there
was a significant induction of caspases 3/7 in THP1 cells treated with
0.625 μg ml–1 of Lipo‐AgNP after 24 hours (P < 0.0001).
Previous studies have linked the AgNP mechanism of action to
increased generation of ROS, which causes depolarization of the mitochondrial membrane potential and subsequent rupture of the membrane for release of cytochrome c (Foldbjerg et al., 2011; Jiang et al.,
2013; Kang et al., 2012). This has been proposed to be achieved by
the intracellular oxidation of AgNP to Ag+ by the acidic environment
in the lysosome (De Matteis et al., 2015). Endocytosis of AgNP is
believed to result in the compartmentalization of the NP in an endosome, which is metabolized in the endolysosomal pathway thus leading
to its oxidation and generation of ROS. Our findings have interestingly
opened an alternative pathway to ROS‐dependent apoptosis induction
by AgNP. In this study, it was shown that encapsulation of AgNP in
liposomes was able to achieve greater cytotoxicity at low dose compared to what was achievable at high doses, in a ROS‐independent
way. This may be attributed to the improved delivery of AgNP into
the cells via the liposome as the lipid layer can easily traverse the lipid

5
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CO NC LUSIO N

In this work, the encapsulation of AgNP in a liposome has been demonstrated to enhance AgNP cytotoxicity at low concentrations through
increased DNA damage with suppression of ROS. This contrast with
several other studies that have shown that AgNP cytotoxic effect
can only be achieved through the generation of ROS. It is postulated
that the encapsulation of AgNP in liposomes could eliminate the negative side effects of ROS making it possible to achieve a greater level
of cytotoxicity that would otherwise only be possible at high concentrations. As such, Lipo‐AgNP could reduce the concentration of AgNP
required thereby increasing any potential biological activity with
reduced associated side effects typically caused from high‐dose
exposures.
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